Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yutaka Ueda

Showing results (331-340 of 359) with videos related to

Pageof 36
Sort By:
International Journal of Hematology|October 7, 2010
Bortezomib plus dexamethasone for relapsed or treatment refractory multiple myeloma: the collaborative study at six institutes in Kyoto and OsakaTsutomu Kobayashi, Junya Kuroda, Kazuho Shimura, et al.
Cancer Chemotherapy and Pharmacology|May 18, 2011
Chemotherapy for endometrial carcinoma (GOGO-EM1 study): TEC (paclitaxel, epirubicin, and carboplatin) is an effective remission-induction and adjuvant therapyTomomi Egawa-Takata, Yutaka Ueda, Chie Kuragaki, et al.
Thoracic Cancer|January 12, 2021
Novel prospective umbrella-type lung cancer registry study for clarifying clinical practice patterns: CS-Lung-003 study protocolKazuya Nishii, Masaaki Inoue, Hideto Obata, et al.
Human Vaccines & Immunotherapeutics|July 31, 2020
A survey of 20-year-old Japanese women: how is their intention to undergo cervical cancer screening associated with their childhood HPV vaccination status?Reisa Kakubari, Tomomi Egawa-Takata, Yutaka Ueda, et al.
BMC Public Health|September 25, 2016
Development of an efficient strategy to improve HPV immunization coverage in JapanAsami Yagi, Yutaka Ueda, Tomomi Egawa-Takata, et al.
Clinical Lung Cancer|December 6, 2018
Phase 2 Study of Afatinib Alone or Combined With Bevacizumab in Chemonaive Patients With Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations: AfaBev-CS Study ProtocolTakashi Ninomiya, Nobuhisa Ishikawa, Koji Inoue, et al.
Annals of Surgical Oncology|March 15, 2023
Novel Strategy for the Management of Cervical Multicystic DiseasesAi Yoshino, Eiji Kobayashi, Takahiro Tsuboyama, et al.
Human Vaccines & Immunotherapeutics|June 9, 2018
Time-dependent changes of the intention of mothers in Japan to inoculate their daughters with the HPV vaccine after suspension of governmental recommendationAsami Yagi, Yutaka Ueda, Yusuke Tanaka, et al.
Maternal and Child Health Journal|February 8, 2023
Awareness of Infectious Disease Screening During Early Pregnancy and Knowledge About its Vertical Transmission in Japan: A Report from the Pregnant Women Health InitiativeMizuha Odagami, Akiko Iwata, Kazumi Kubota, et al.
International Journal of Clinical Oncology|September 6, 2025
Prognostic factors of lenvatinib plus pembrolizumab therapy for advanced or recurrent endometrial cancer: analysis of a multicenter cohort study in JapanYoshikazu Nagase, Satoshi Nakagawa, Mariya Kobayashi, et al.
Pageof 36

Showing results (331-340 of 359) with videos related to

Sort By:
Pageof 36
International Journal of Hematology|October 7, 2010
Bortezomib plus dexamethasone for relapsed or treatment refractory multiple myeloma: the collaborative study at six institutes in Kyoto and OsakaTsutomu Kobayashi, Junya Kuroda, Kazuho Shimura, et al.
Cancer Chemotherapy and Pharmacology|May 18, 2011
Chemotherapy for endometrial carcinoma (GOGO-EM1 study): TEC (paclitaxel, epirubicin, and carboplatin) is an effective remission-induction and adjuvant therapyTomomi Egawa-Takata, Yutaka Ueda, Chie Kuragaki, et al.
Thoracic Cancer|January 12, 2021
Novel prospective umbrella-type lung cancer registry study for clarifying clinical practice patterns: CS-Lung-003 study protocolKazuya Nishii, Masaaki Inoue, Hideto Obata, et al.
Human Vaccines & Immunotherapeutics|July 31, 2020
A survey of 20-year-old Japanese women: how is their intention to undergo cervical cancer screening associated with their childhood HPV vaccination status?Reisa Kakubari, Tomomi Egawa-Takata, Yutaka Ueda, et al.
BMC Public Health|September 25, 2016
Development of an efficient strategy to improve HPV immunization coverage in JapanAsami Yagi, Yutaka Ueda, Tomomi Egawa-Takata, et al.
Clinical Lung Cancer|December 6, 2018
Phase 2 Study of Afatinib Alone or Combined With Bevacizumab in Chemonaive Patients With Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations: AfaBev-CS Study ProtocolTakashi Ninomiya, Nobuhisa Ishikawa, Koji Inoue, et al.
Annals of Surgical Oncology|March 15, 2023
Novel Strategy for the Management of Cervical Multicystic DiseasesAi Yoshino, Eiji Kobayashi, Takahiro Tsuboyama, et al.
Human Vaccines & Immunotherapeutics|June 9, 2018
Time-dependent changes of the intention of mothers in Japan to inoculate their daughters with the HPV vaccine after suspension of governmental recommendationAsami Yagi, Yutaka Ueda, Yusuke Tanaka, et al.
Maternal and Child Health Journal|February 8, 2023
Awareness of Infectious Disease Screening During Early Pregnancy and Knowledge About its Vertical Transmission in Japan: A Report from the Pregnant Women Health InitiativeMizuha Odagami, Akiko Iwata, Kazumi Kubota, et al.
International Journal of Clinical Oncology|September 6, 2025
Prognostic factors of lenvatinib plus pembrolizumab therapy for advanced or recurrent endometrial cancer: analysis of a multicenter cohort study in JapanYoshikazu Nagase, Satoshi Nakagawa, Mariya Kobayashi, et al.
Pageof 36